Verona Pharma PLC (VRNA)
46.59
-1.61
(-3.34%)
USD |
NASDAQ |
Jan 03, 16:00
45.81
-0.78
(-1.67%)
After-Hours: 20:00
Verona Pharma Total Assets (Quarterly): 381.82M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 8.691M |
| Adaptimmune Therapeutics PLC | 317.44M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Bicycle Therapeutics PLC | 996.75M |
| Autolus Therapeutics PLC | 827.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 251.33M |
| Shareholders Equity (Quarterly) | 130.49M |
| Debt to Equity Ratio | 0.9197 |
| Current Ratio | 13.03 |
| Net Debt Paydown Yield | -0.85% |